Iron deficiency anemia pathophysiology

Revision as of 14:22, 5 September 2018 by Jogeet singh sekhon (talk | contribs)
Jump to navigation Jump to search

Iron deficiency anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Iron deficiency anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Iron deficiency anemia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Iron deficiency anemia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Iron deficiency anemia pathophysiology

CDC on Iron deficiency anemia pathophysiology

Iron deficiency anemia pathophysiology in the news

Blogs on Iron deficiency anemia pathophysiology

Directions to Hospitals Treating Iron deficiency anemia

Risk calculators and risk factors for Iron deficiency anemia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Pathophysiology

Physiology

  • Iron is needed for the synthesis of haemoglobin, new DNA synthesis and is a major component of oxidation and reduction enzymes.
  • In the human body, iron mainly exists as bound to protein (hemoprotein), as heme compounds (hemoglobin or myoglobin), heme enzymes, or nonheme compounds (flavin-iron enzymes, transferring, and ferritin).
  • The body requires iron for the synthesis of its oxygen transport proteins, (hemoglobin and myoglobin), and for the formation of heme enzymes and other iron-containing enzymes involved in electron transfer and oxidation-reductions.
  • Human iron metabolism is controlled by various factors.
  • 60% of the body iron is found in the hemoglobin present in circulating erythrocytes, 25% is contained in tranferrin and ferritin, and the remaining 15% is bound to myoglobin in muscle tissue and in a variety of enzymes involved in the oxidative metabolism and many other cell functions.
  • Iron is bound and transported in the body via transferrin and stored in ferritin molecules.
  • Iron is delivered to tissues by circulating transferrin, a transporter that captures iron released into the plasma from intestinal enterocytes or reticuloendothelial macrophages.
  • The binding of transferrin to the cell-surface transferrin receptor (TfR) 1 results in endocytosis and uptake of iron.
  • Internalized iron is transported to mitochondria for the synthesis of heme or other iron containing enzymes.
  • Excess iron is stored in cytosolic ferritin.

Absorption of iron

  • Iron absorption occurs by the enterocytes in the duodenum and upper jejunum.
  • Dietary iron occurs in two forms: heme and nonheme. The primary sources of heme iron are hemoglobin and myoglobin from consumption of meat, poultry, and fish, whereas nonheme iron is obtained from cereals, pulses, legumes, fruits, and vegetables.
  • In the blood, it is transported by transferrin to the cells or the bone marrow for erythropoiesis.
  • Iron absorption is controlled by ferroportin which allows or does not allow iron from the mucosal cell into the plasma.
  • Iron is absorbed in Fe+2 (ferric) state
  • The iron is consumed in Fe+3 (ferrous) state and is reduced to Fe+2 state by the acidic gastric pH by enzyme ferric reductase.
  • Fe+2 is absorbed by the enterocytes and exported across the basolateral membrane into the bloodstream via Fe+2 transporter ferroportin.
  • The ferroportin-mediated efflux of Fe+2 is coupled by its reoxidation to Fe+3, catalyzed by ferroxidase hephaestin that interacts with ferroportin.
  • The total iron content of transferrin is dynamic and undergoes changes to sustain erythropoiesis.
  • Senescent RBCs are cleared by reticuloendothelial macrophages, which metabolize hemoglobin and heme, and release iron into the bloodstream.
  • The transferrin iron pool is replenished by iron recycled from RBCs and by newly absorbed dietary iron
  • Macrophages export Fe+2 from their plasma membrane via ferroportin, in a process coupled by reoxidation of Fe+2 to Fe+3 by ceruloplasmin and followed by the loading of Fe+3 to transferrin.

Regulation of iron homeostasis

  • Iron balance is mainly regulated at the point of absorption.
  • Hepcidin is a circulating peptide hormone secreted by the liver that plays a central role in the regulation of iron homeostasis.
  • This hormone is produced by hepatocytes and is a negative regulator of iron entry into plasma.
  • Hepcidin acts by binding to ferroportin.
  • Binding of hepcidin induces ferroportin degradation.
  • The loss of ferroportin from the cell surface prevents iron entry into plasma and decreased iron levels in the body.
  • Decreased expression of hepcidin leads to increased cell surface ferroportin and increased iron absorption.
  • Plasma hepcidin levels are regulated by cytokines, plasma iron, anemia, and hypoxia.
  • Overexpression of hepcidin leads to the anemia of chronic disease, while low hepcidin production results in hereditary hemochromatosis (HFE)
  • with consequent iron accumulation in vital organs [Figure 2]. Most hereditary iron disorders result from inadequate hepcidin production relative to the degree of tissue iron accumulation. Impaired hepcidin expression has been shown to result from mutations in any of 4 different genes: TfR2, HFE, hemochromatosis type 2 (HFE2), and hepcidin antimicrobial peptide (HAMP). Mutations in HAMP, the gene that encodes hepcidin, result in iron overload disease, as the absence of hepcidin permits constitutively high iron absorption. The role for other genes (TFR2, HFE, and HFE2) in the regulation of hepcidin production has been unclear.[27]

Storage

  • Ferritin concentration together with that of hemosiderin reflects the body iron stores.
  • They store iron in an insoluble form and are present primarily in the liver, spleen, and bone marrow.
  • Serum ferritin is the most convenient laboratory test to estimate iron stores.

Factors effecting iron absorption

  • Factors that enhance iron uptake are:
    • Ascorbate and citrate increase iron uptake by acting as weak chelators.
    • Iron is readily transferred from these compounds into the mucosal lining cells.
  • Factors inhibiting iron absorption are:
    • Phytate (myo-inositol hexakisphosphate) is the main inhibitor of iron absorption.
    • Calcium
    • Animal proteins such as milk proteins, egg proteins, and albumin, have been shown to inhibit iron absorption.
    • Proteins from soybean also decrease iron absorption.
    • Suppresion of gastri acide such as use of antacids suprress iron absorption.
    • Lead competes with iron for the absorption and blocks its absorption by competetive inhibition.

Iron requirement

Recommended Dietary Allowances (RDAs) for Iron
Age Male Female Pregnancy Lactation
Birth to 6 months 0.27 mg* 0.27 mg*
7–12 months 11 mg 11 mg
1–3 years 7 mg 7 mg
4–8 years 10 mg 10 mg
9–13 years 8 mg 8 mg
14–18 years 11 mg 15 mg 27 mg 10 mg
19–50 years 8 mg 18 mg 27 mg 9 mg
51+ years 8 mg 8 mg

Pathogenesis

  • Iron deficiency anemia occurs when there is:
    • Low dietary intake.
    • Increased demands of iron.
    • Impaired absorption of iron.
    • Excessive loss of iron (blood loss).
    • Increased hepcidin (chronic inflammation)
  • Low dietary intake:
    • Iron is obtained from foods such as:
      • meat, such as lamb, pork, chicken, and beef
      • beans
      • pumpkin and squash seeds
      • leafy greens, such as spinach
      • raisins and other dried fruit
      • eggs
      • seafood, such as clams, sardines, shrimp, and oysters
      • iron-fortified dry and instant cereals Foods high in vitamin C include:
      • fruits such as oranges, grapefruits, strawberries, kiwis, guavas, papayas, pineapples, melons, and mangoes
        • broccoli
      • red and green bell peppers
      • Brussels sprouts
      • cauliflower
      • tomatoes
      • leafy greens
    • Increased demands of iron
      • Growth, the requirement of iron increases during the developmental period from infancy to adolescence and during adolescence.
      • Pregnancy, during pregnancy the demand for iron is increased.
    • Impaired absorption of iron:
    • Excessive loss of iron (blood loss)
      • The only means of excertion for iron is through blood loss.
      • Any source of external and internal bleeding can cause iron deficiency depending on the blood loss.
    • Increased hepcidin
      • In chonric inflammatory conditions, the levels of hepcidin increase.
      • Increased hepcidin causes ferriportin degeneration and impaired iron absorption.
  • Iron is required for haemoglobin synthesis, so deficiency of iron leads to depletion of haemoglobin.
  • Decrease in haemoglobin leads to anemia.
  • Due to low haemoglobin, oxygen is not tranported effectively to cells and results in hypoxia.
Population Hb Diagnostic of anaemia (g/dL)a
Children aged 6 months to 6 years old <11.0
Children aged 6-14 years old <12.0
Adult men <13.0
Adult non-pregnant women <12.0
Adult pregnant women <11.0

Histology

(Images shown below are courtesy of Melih Aktan MD, Istanbul Medical Faculty - Turkey)

Video

{{#ev:youtube|7uDbu7esZik}}

External Link

Center for disease control and prevention

References

Template:WH Template:WS